Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes
Status:
Recruiting
Trial end date:
2023-04-30
Target enrollment:
Participant gender:
Summary
A randomised controlled, open-label trial in an unselected cohort of pregnant women with type
1 or type 2 diabetes allocated to insulin Fiasp® or insulin NovoRapid® during pregnancy and
lactation.